Search Ontology:
ChEBI

beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-D-GlcpNAc

Term ID
CHEBI:147191
Synonyms
  • beta-D-galacto-hexopyranosyl-(1->4)-[beta-D-gluco-hexopyranosyl-(1->6)]-2-acetamido-2-deoxy-D-gluco-hexopyranose
  • beta-D-galactopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->6)]-2-acetamido-2-deoxy-D-glucopyranose
  • Gal(b1-4)[Glc(b1-6)]GlcNAc
  • N-[(3R,4R,5S,6R)-2,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-3-yl]acetamide
Definition
An aminotrisaccharide that is 2-acetamido-2-deoxy-D-glucopyranose in which the hydroxy groups at positions 4 and 6 have been glycosylated by a β-D-galactopyranosyl group and a β-D-glucopyranosyl group, respectively.
References
  • glygen:G07619BL
  • glytoucan:G07619BL
  • kegg.glycan:G07993
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-D-GlcpNAc
Phenotype where environments contain beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-D-GlcpNAc
Phenotype modified by environments containing beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-D-GlcpNAc
Phenotype affecting beta-D-Galp-(1->4)-[beta-D-Glcp-(1->6)]-D-GlcpNAc
Human Disease Model